COVID-19 Australia: Epidemiology Report 81 Reporting period ending 19 November 2023
DOI:
https://doi.org/10.33321/cdi.2024.48.4Keywords:
SARS-CoV-2, novel coronavirus, coronavirus disease 2019, COVID-19, acute respiratory disease, epidemiology, AustraliaAbstract
Four-week reporting period (23 October – 19 November 2023)
Case definitions for confirmed and probable cases are in accordance with the coronavirus disease 2019 (COVID-19) CDNA National Guidelines for Public Health Units.
Trends – Nationally, case notifications have slowly increased from late August to early September 2023, and have stabilised in recent weeks. In the four-week period 23 October – 19 November 2023, there were 26,871 confirmed and 11,612 probable cases, a total of 38,483 COVID-19 cases reported in Australia to the National Notifiable Diseases Surveillance System (NNDSS). In the most recent reporting fortnight, a total of 20,598 confirmed and probable cases were notified (an average of 1,471 cases per day), compared to 17,885 in the previous fortnight (an average of 1,278 cases per day), representing a 15% increase.
Downloads
References
COVID-19 National Incident Room Surveillance Team. COVID-19 Australia: Epidemiology Report 80: Reporting period ending 22 October 2023. Commun Dis Intell (2018). 2024;48. doi: https://doi.org/10.33321/cdi.2024.48.3.
COVID-19 National Incident Room Surveillance Team. Technical supplement. COVID-19 Australia: Epidemiology reporting. Commun Dis Intell (2018). 2021;45. doi: https://doi.org/10.33321/cdi.2021.45.2.
Australian Government Department of Health and Aged Care. Coronavirus (COVID-19) – CDNA National Guidelines for Public Health Units. [Internet.] Canberra: Australian Government Department of Health and Aged Care; 14 October 2022. [Accessed on 9 November 2022.] Available from: https://www.health.gov.au/resources/publications/coronavirus-covid-19-cdna-national-guidelines-for-public-health-units.
FluCAN (The Influenza Complications Alert Network). FluCAN (Influenza surveillance). [Webpage.] Melbourne: Monash Health, FluCAN. [Accessed on 30 June 2023.] Available from: https://monashhealth.org/services/monash-infectious-diseases/research/influenza-research/flucan-influenza-surveillance-2/.
Australian and New Zealand Intensive Care Research Centre (ANZIC-RC). SPRINT-SARI: Short period incidence study of severe acute respiratory infection. [Internet.] Melbourne: Monash University, ANZIC-RC; 2020. Available from: https://www.monash.edu/medicine/sphpm/anzicrc/research/sprint-sari.
Communicable Diseases Genomics Network (CDGN). AusTrakka. [Website.] Melbourne: CDGN; 2020. Available from: https://www.cdgn.org.au/austrakka.
World Health Organization (WHO). Updated working definitions and primary actions for SARS-CoV-2 variants. Geneva: WHO; 15 March 2023. [Accessed on 11 October 2023.] Available from: https://www.who.int/publications/m/item/updated-working-definitions-and-primary-actions-for--sars-cov-2-variants.
WHO. Tracking SARS-CoV-2 variants. [Webpage.] Geneva: WHO; 17 August 2023. [Accessed on 23 August 2023.] Available from: https://www.who.int/activities/tracking-SARS-CoV-2-variants.
Dalton C, Durrheim D, Fejsa J, Francis L, Carlson S, d’Espaignet ET et al. Flutracking: a weekly Australian community online survey of influenza-like illness in 2006, 2007 and 2008. Commun Dis Intell Q Rep. 2009;33(3):316–22.
WHO. COVID-19 epidemiological update – 24 November 2023. [Internet.] Geneva: WHO;
November 2023. [Accessed on 8 December 2023.] Available from: https://www.who.int/publications/m/item/covid-19-epidemiological-update---24-november-2023.
WHO. Coronavirus disease (COVID-19) Weekly Epidemiological Updates and Monthly Operational Updates. [Webpage.] Geneva: WHO; 2024. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
